Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA - Concepedia

Concepedia

Publication | Closed Access

Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA

30

Citations

35

References

2019

Year

Marzia Del Re, Iacopo Petrini, Francesca Mazzoni, Simona Valleggi, Giulia Gianfilippo, Daniele Pozzessere, Antonio Chella, Stefania Crucitta, Eleonora Rofi, Giuliana Restante,

Clinical Lung Cancer

MedicineMalignant Blood DisorderImmunologyPathologyCirculating Cell-free DnaMolecular DiagnosticsOncologyGenomic Medicine

References

	Year	Citations

Page 1

Page 1